These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38250164)

  • 1. Adherence to quality indicators and best practices in surveillance endoscopy of Barrett's esophagus: A video-based assessment.
    Enke T; Keswani R; Triggs J; Gannavarapu B; Mittal C; Sinha J; Kwasny MJ; Komanduri S
    Endosc Int Open; 2024 Jan; 12(1):E90-E96. PubMed ID: 38250164
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett's Esophagus: Expert Review.
    Muthusamy VR; Wani S; Gyawali CP; Komanduri S;
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2696-2706.e1. PubMed ID: 35788412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to quality indicators and surveillance guidelines in the management of Barrett's esophagus: a retrospective analysis.
    Westerveld D; Khullar V; Mramba L; Ayoub F; Brar T; Agarwal M; Forde J; Chakraborty J; Riverso M; Perbtani YB; Gupte A; Forsmark CE; Draganov P; Yang D
    Endosc Int Open; 2018 Mar; 6(3):E300-E307. PubMed ID: 29507870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wide Variability in Dysplasia Detection Rate and Adherence to Seattle Protocol and Surveillance Recommendations in Barrett's Esophagus: A Population-Based Analysis Using the GIQuIC National Quality Benchmarking Registry.
    Kolb JM; Davis C; Williams JL; Holub J; Shaheen N; Wani S
    Am J Gastroenterol; 2023 May; 118(5):900-904. PubMed ID: 36623168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to guideline recommendations for Barrett's esophagus (BE) surveillance endoscopies: Effects of dedicated BE endoscopy lists.
    Beaufort IN; Milne AN; Alderlieste YA; Baars JE; Bos PR; Burger JPW; van Heel NCM; Ledeboer M; Lieverse RJ; van de Meeberg PC; Meeuse JJ; Naber AHJ; Pullens HJM; Scheffer RCH; Sikkema M; Verbeek RE; Verhagen MAMT; van de Vrie W; Willems M; Weusten BLAM
    Endosc Int Open; 2023 Oct; 11(10):E952-E962. PubMed ID: 37828974
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation of the Prague C&M classification of Barrett's esophagus in clinical practice.
    Alvarez Herrero L; Curvers WL; van Vilsteren FG; Wolfsen H; Ragunath K; Wong Kee Song LM; Mallant-Hent RC; van Oijen A; Scholten P; Schoon EJ; Schenk EB; Weusten BL; Bergman JG
    Endoscopy; 2013 Nov; 45(11):876-82. PubMed ID: 24165812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopists systematically undersample patients with long-segment Barrett's esophagus: an analysis of biopsy sampling practices from a quality improvement registry.
    Wani S; Williams JL; Komanduri S; Muthusamy VR; Shaheen NJ
    Gastrointest Endosc; 2019 Nov; 90(5):732-741.e3. PubMed ID: 31085185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of advanced endoscopic imaging on Barrett's esophagus in daily clinical practice.
    Beg S; Mensa M; Fullard M; Finerty E; Richman P; Leahy A
    Gastrointest Endosc; 2018 May; 87(5):1189-1194. PubMed ID: 28958906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate.
    Ooi J; Wilson P; Walker G; Blaker P; DeMartino S; O'Donohue J; Reffitt D; Lanaspre E; Chang F; Meenan J; Dunn JM
    Endoscopy; 2017 Jun; 49(6):524-528. PubMed ID: 28399610
    [No Abstract]   [Full Text] [Related]  

  • 11. Adherence to quality indicators in endoscopic surveillance of Barrett's esophagus and correlation to dysplasia detection rates.
    Antony A; Pohanka C; Keogh S; Klein R; Alshelleh M; Lee C; Trindade AJ
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):591-596. PubMed ID: 30033206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to clinical guidelines for Barrett's esophagus.
    Holmberg D; Ness-Jensen E; Mattsson F; Lagergren J
    Scand J Gastroenterol; 2019 Aug; 54(8):945-952. PubMed ID: 31314608
    [No Abstract]   [Full Text] [Related]  

  • 13. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy.
    Eloubeidi MA; Provenzale D
    Am J Gastroenterol; 1999 Apr; 94(4):937-43. PubMed ID: 10201460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.
    Corley DA; Mehtani K; Quesenberry C; Zhao W; de Boer J; Weiss NS
    Gastroenterology; 2013 Aug; 145(2):312-9.e1. PubMed ID: 23673354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus?
    Gorrepati VS; Sharma P
    Dig Dis Sci; 2018 Aug; 63(8):2115-2121. PubMed ID: 29675664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best Practices in Surveillance for Barrett's Esophagus.
    Triggs JR; Falk GW
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):59-75. PubMed ID: 33213800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression or regression of Barrett's esophagus--is it all in the eye of the beholder?
    Dekel R; Wakelin DE; Wendel C; Green C; Sampliner RE; Garewal HS; Martinez P; Fass R
    Am J Gastroenterol; 2003 Dec; 98(12):2612-5. PubMed ID: 14687805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review.
    Qumseya BJ; Wang H; Badie N; Uzomba RN; Parasa S; White DL; Wolfsen H; Sharma P; Wallace MB
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1562-70.e1-2. PubMed ID: 23851020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
    Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
    Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.